Effect of screening result on waiting times to assessment and breast cancer diagnosis: Results from the Ontario Breast Screening Program

Canadian Journal of Public Health

Volumn 96, Issue 4, 2005, Pages 259-263

  Chiarelli, Anna M ^a,b   Mai, Verna ^a,b   Halapy, Erika E ^a   Shumak, Rene S ^a   O'Malley, Frances P ^c   Klar, Neil S ^a,b  

^a CANCER CARE ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Breast cancer; Mammography; Mass screening; Physical examination; Prognosis; Time factors

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANADA; CANCER SCREENING; CANCER SIZE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PATIENT REFERRAL; PHYSICAL EXAMINATION; PROGNOSIS; TIME;

EID: 24144494557     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405159     Document Type: Article

References (23)

1. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.
2. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening. A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137:347-60.
3. IARC Working Group. Handbooks of Cancer Prevention, Volume 7: Breast Cancer Screening. Lyon, France: IARC Press, 2002;87-117.
4. The Workshop Group. Reducing deaths from breast cancer in Canada-Workshop report. CMAJ 1989;141:199-201.
5. Rimer BK, Bluman LG. The psychosocial consequences of mammography. J Nat Cancer Inst Monogr 1997;22:131-38.
6. Bret J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Pub Health Med 1998;20:396-403.
7. Brett J, Austoker J. Women who are recalled for further investigation for breast screening: Psychological consequences 3 years after recall and factors affecting reattendance. J Pub Health Med 2001;23:292-300.
8. Olivotto IA, Gomi A, Bancej C, Brisson J, Tonita J, Kan L, et al. Influence to delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 2002;94:2143-50.
9. Ganry O, Peng J, Dubreuil A. Influence of abnormal screen on delays and prognostic indicators of screen-detected breast carcinoma. J Med Screen 2004;11:28-31.
10. Caplan LS, May DS, Richardson L. Time to diagnosis and treatment of breast cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health 2000;90:130-34.
11. Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ 2001;165:277-83.
12. Duijm LEM, Groenewould JH, Jansen FH, Fracheboud J, vanBeek M, deKoning HJ. Mammography screening in the Netherlands: Delay in the diagnosis of breast cancer after breast cancer screening. Br J Cancer 2004;91;1795-99.
13. Shootman M, Myers-Geadelmann J, Laurence F. Factors associated with adequacy of diagnostic workup after abnormal breast cancer screening results. J Am Board Fam Pract 2000;13:94-100.
14. Ballard-Barbash R, Klabunde C, Paci E, Broeders M, Coleman EA, Fracheboud J, et al. Breast cancer screening in 21 countries: Delivery of services, notification of results and outcome ascertainment. Eur J Cancer Prev 1999;8:417-26.
15. Libstug AR, Moravan V, Aitken SE. Results from the Ontario Breast Screening Program, 1990-1995. J Med Screen 1998;5:73-80.
16. Kuzma JW, Bohnenblust SE. Basic Statistics for the Health Sciences. Mountain View, CA: Mayfield Publishing Company, 2001; 238-45.
17. SAS Institute Inc.: SAS System version 6.12. Cary, North Carolina, 1989-1996.
18. Psooy BJ, Schreuer D, Borganokar J, Caines JS. Patient navigation: Improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J 2004;55:145-50.
19. Olivotto IA, Borugian MJ, Kan L, Harris SR, Rousseau EJ, Thorne SE, et al. Improving the time to diagnosis after an abnormal screening mammogram. Can J Public Health 2001;92:366-71.
20. Decker KM, Harrison M, Chateau D. Influence of direct referrals on time to diagnosis after an abnormal breast screening result. Cancer Detection and Prevention 2004;28:361-67.
21. Miller AB. Organized breast cancer screening in Canada. CMAJ 2000;163:1150-51.
22. Report of the Working Group on the Integration of Screening and Diagnosis for the Canadian Breast Cancer Screening Initiative. Waiting for a diagnosis after an abnormal breast cancer screen in Canada. Ottawa: Health Canada, 2000. Cat No. H39-526/2000E, pp. 21-22. http://www.phac-aspc.gc.ca/ccdpc-cpcmc/bc-cds/pdf/diagnosis-report_e.pdf.
23. Canadian Breast Cancer Screening Initiative. Organized Breast Cancer Screening Programs in Canada: 1999 and 2000 Report. Ottawa: Health Canada, 2003. Cat. No. H1-9/13-2000, pp 27. http://www.phac-aspc.gc.ca/publicat/obcsp-podcs00/index.html.